News & Videos - NEUROMETRIX INC.

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of NeuroMetrix, Inc. (NasdaqCM: NURO) to electroCore, Inc. Under the terms of the proposed transaction, shareholders of NeuroMetrix will receive one non-tradeable contingent value right (the “CVR”) per share of NURO common stock owned. Each CVR will represent the right to receive (i) certain future net proceeds from any divestiture of...

SHAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of NeuroMetrix, Inc. - NURO PR Newswire NEW YORK, Dec. 18, 2024 NEW YORK , Dec. 18, 2024 /PRNewswire/ -- Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm by ISS Securities Class Action Services Report. We are headquartered at the Empire State Building in New York City and are investigating NeuroMetrix, Inc. (NASDAQ: NURO ) , relating...

Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of NeuroMetrix, Inc. (NASDAQ: NURO) to electroCore, Inc. is fair to NeuroMetrix shareholders. Halper Sadeh encourages NeuroMetrix shareholders to click here to learn more about their legal rights and options or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or [email protected] or [email protected] . The investigation concerns whether NeuroMetrix and its board of directors violated the federal...

NURO stock price has declined 99% since its IPO Gozani has received compensation of over $10 million since the IPO Gozani was charged by the FTC for various wrongdoings at NURO Gozani apparently personally paid the FTC $4 million as part of a settlement Gozani barely owns any NURO shares NURO continues to sell stock significantly below its net cash value NEW YORK, NY / ACCESSWIRE / March 12, 2024 / Earlier today Echo Lake Capital sent a letter to the Board of Directors of Neurometrix, Inc....

- Stock trades significantly below its net cash per share - Questions the Board's ability and/or desire to create shareholder value - Notes tremendous destruction of shareholder value under company's leadership - Sees no reason for company to remain public NEW YORK, NY / ACCESSWIRE / March 4, 2024 / On February 27, 2024, Ephraim Fields of Echo Lake Capital filed a Schedule 13D which included a letter to the Board of Directors of Neurometrix, Inc. (NASDAQ:NURO) . The letter described his belief...

Thinking about buying stock in Neurometrix, Palantir Technologies, EQT Corp, Occidental Petroleum, or Robinhood Markets? PR Newswire NEW YORK, Jan. 18, 2022 NEW YORK , Jan. 18, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for NURO, PLTR, EQT, OXY, and HOOD. To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link. NURO:...

Thinking about buying stock in Camber Energy, Eargo, Neurometrix, Tilray, or Vipshop Holdings? PR Newswire NEW YORK, Sept. 23, 2021 NEW YORK , Sept. 23, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for CEI, EAR, NURO, TLRY, and VIPS. To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link. CEI:...

...

...

...

...

NeuroMetrix To Introduce Quell 2.0: The Next Generation, Wearable Pain Relief Technology at PAINWeek 2018 Company will launch its latest innovation at national conference on pain management PR Newswire LAS VEGAS, Sept. 4, 2018 LAS VEGAS , Sept. 4, 2018 /PRNewswire/ -- Tomorrow at PAINWeek 2018, NeuroMetrix Inc. (Nasdaq: NURO) , will unveil its latest breakthrough for the treatment of chronic pain. Quell® 2.0 takes the company's FDA cleared, 100% drug-free, prescription strength nerve...

...

NEW YORK, NY / ACCESSWIRE / October 19, 2017 / NeuroMetrix, Inc. (NASDAQ: NURO ) will be discussing their earnings results in their Q3 Earnings Call to be held October 19, 2017 at 8:00 AM Eastern Time. To listen to the event live - visit https://www.investornetwork.com/company/22336 . Replay Information The replay will be available online at https://www.investornetwork.com/company/22336 . About Investor Network Investor Network (IN) is a financial content community, serving millions of unique...

NEW YORK, NY / ACCESSWIRE / July 20, 2017 / NeuroMetrix, Inc. (NASDAQ: NURO ) will be discussing their earnings results in their Q2 Earnings Call to be held on Thursday, July 20, 2017 at 8:00 AM Eastern Time. To listen to the event live - visit https://www.investornetwork.com/company/22336 . Replay Information The replay will be available online at https://www.investornetwork.com/company/22336 . About Investor Network Investor Network (IN) is a new financial content community, serving millions...